The pharmaceutical industry in Ukraine is amongst the ten biggest pharmaceutical industries in the Central and Eastern European (CEE) region. With the country adopting new healthcare reform bills from January 2018, the overall outlook for the healthcare and pharmaceutical industry has improved considerably. Both pharmaceutical and healthcare spending is expected to increase in the coming years as the lockdown restrictions are eased, and COVID-19 related vaccine purchases drive up the demand for associated services.
Up until 2014, the Ukrainian pharmaceutical industry was primarily dominated by foreign companies. However, in recent years, Ukrainian companies are making their mark felt in the sector, with Farmak International and Arterium Corporation emerging as the leading industry players.
The publisher presents an in-depth analysis of the Pharmaceutical and Healthcare Industry of Ukraine in its research report Pharmaceutical and Healthcare Industry in Ukraine - Forecast and Analysis 2021.
The report covers the following data:
- An in-depth coverage of the pharmaceutical and healthcare industry in Ukraine by sectors along with an analysis of how the COVID-19 pandemic is effecting the industry.
- We analyze the segments of prescription drugs, generic drugs, OTC medicines, and also analyze the landscape for clinical trials in Ukraine.
- A SWOT analysis of the Ukrainian pharmaceutical and healthcare industry.
- We take an up-close view of the regulatory framework governing the Ukrainian pharmaceutical and healthcare industry.
- Competition in the industry, along with an in-depth analysis of the major domestic and multinational players like Farmac, Arterium Corporation, AstraZeneca, Eli Lilly, Glaxo Smith Kline, and many others are included.
A detailed forecast of the Ukrainian pharmaceutical and healthcare industry by segments completes this comprehensive analysis.
Table of Contents
Companies Mentioned
- Arterium Corporation
- Farmak International
- AbbVie
- AstraZeneca
- GlaxoSmithKline
- Johnson & Johnson
- Merck & Co
- Novartis
- Pfizer
- Sanofi SA
- Takeda Pharmaceutical